Panic Disorders Global Market Report 2024

Description

Panic disorder is a specific type of anxiety condition characterized by unexpected and recurring episodes of intense anxiety accompanied by physical symptoms such as shortness of breath, chest pain, heart palpitations, nausea, and abdominal discomfort. Treatment for panic disorder typically involves a combination of medication and psychotherapy.

The main subtypes of panic disorders include agoraphobia, social anxiety disorder (SAD), obsessive-compulsive disorder (OCS), bipolar disorder, post-traumatic stress disorder (PTSD), and major depressive disorder. Agoraphobia involves the intentional avoidance of places or situations that may trigger panic symptoms, leading to feelings of confinement, helplessness, or social discomfort. Various treatment options include medication, beta-blockers, serotonin and norepinephrine reuptake inhibitors (SNRIs), benzodiazepines, anti-epilepsy medications, and others, which can be administered orally, through injections, and other methods. These treatments are available through hospital pharmacies, retail pharmacies, and online pharmacy stores.

The panic disorders market research report is one of a series of new reports from The Business Research Company that provides panic disorders market statistics, including panic disorders industry global market size, regional shares, competitors with a panic disorders market share, detailed panic disorders market segments, market trends and opportunities, and any further data you may need to thrive in the panic disorders industry. This panic disorders market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The panic disorders market size has grown strongly in recent years. It will grow from $10.19 billion in 2023 to $10.73 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historical period can be attributed to the use of antidepressant medications, heightened awareness of mental health issues, rising stress levels, improved access to mental health services, and advancements in diagnostic criteria.

The panic disorders market size is expected to see strong growth in the next few years. It will grow to $13.07 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to the emergence of pharmacological treatments, the expansion of telepsychiatry services, a focus on comorbidities, global mental health initiatives, the integration of pharmacogenomics in treatment, and public education programs. Major trends in the forecast period include digital mental health interventions, the use of telemedicine for panic disorder treatment, innovations in medications, advancements in neurobiological research, and the adoption of remote monitoring and wearable technology.

An upsurge in the population of psychiatric patients is poised to propel the expansion of the panic disorder market in the foreseeable future. Psychiatric patients, affected by mental health conditions that disrupt various aspects of their cognitive, emotional, and social functioning, are susceptible to panic disorder, characterized by sudden and intense episodes of anxiety. Treatment for individuals dealing with psychiatric conditions often involves a multifaceted approach combining therapy, medication, and lifestyle modifications to alleviate panic attack symptoms, enhance overall well-being, and foster effective coping mechanisms. For instance, the State of Mental Health in America 2022 report by Mental Health America noted an increase in psychiatric patients, reaching 49,564,000 individuals, constituting 19.86% of the total US population in 2022, compared to 47,132,000 individuals, comprising 19.00% of the total US population in 2021. Hence, the rise in psychiatric patient numbers is set to drive the growth of the panic disorder market.

The growing adoption of telehealth services is anticipated to propel the expansion of the panic disorders market in the coming years. Telehealth leverages electronic communication technologies such as video conferencing, phone calls, and secure messaging to deliver remote healthcare services and consultations. In the realm of panic disorders, telehealth enables psychotherapy and counseling services, offering platforms for therapists to conduct individual or group therapy sessions, as well as support groups, through secure video conferencing tools. As an illustration, a report by FAIR Health Inc. highlighted a 7.3% national increase in telehealth usage, from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. This growing reliance on telehealth platforms signifies a driving force behind the growth of the panic disorders market.

The high costs associated with panic disorder treatment and the limitations in insurance coverage can pose significant challenges, potentially restricting the market's growth during the forecast period. The expenses linked to managing panic disorder are often substantial due to the necessity for prolonged therapy, medications, and specialized care. Moreover, the constrained insurance coverage for mental health services frequently results in patients having to bear a significant portion of the treatment expenses. For instance, a report from Addiction Rehab Toronto in May 2021 indicated that anxiety treatment for a two-week session cost around $8,000, with a potential increase of $2,000 for treating PTSD and panic attacks. Cognitive-behavioral therapy (CBT) sessions could cost up to $100 per hour. Hence, the high treatment costs and limited insurance coverage serve as hindrances to the expansion of the panic disorder market.

Key companies engaged in the panic disorder market are concentrating on the development of advanced medications, notably extended-release capsules, to fortify their foothold in the market. Extended-release capsules are medications designed to gradually release the active ingredients over an extended period, typically 12 or 24 hours, suitable for managing conditions requiring prolonged medication. As an example, in May 2023, Granules India Ltd., an Indian pharmaceutical company, obtained abbreviated new drug application (ANDA) approval from the US Food & Drug Administration (USFDA) for Venlafaxine hydrochloride extended-release capsules. These capsules have demonstrated bioequivalence with the reference-listed drug product (RLD), Effexor XR Extended-Release Capsules, manufactured by Upjohn US 2 LLC. Venlafaxine HCl extended-release capsules are prescribed to manage various conditions such as generalized anxiety disorder (GAD), major depressive disorder (MDD), panic disorder (PD), and social anxiety disorder (SAD). They operate by increasing serotonin and norepinephrine levels in the brain, usually starting at a dosage of 75 mg per day and adjusted as required under a doctor's supervision.

In February 2023, Vistagen Therapeutics Inc., a clinical-stage biopharmaceutical company based in the United States, successfully acquired Pherin Pharmaceuticals Inc. for an undisclosed sum. This strategic acquisition positions Vistagen to advance and bring to market innovative treatments designed for individuals dealing with depression and anxiety disorders. The collaboration is anticipated to enhance the commercial prospects of each drug candidate, strengthening Vistagen's portfolio in addressing mental health challenges. Pherin Pharmaceuticals Inc., the acquired company, specializes in drug development focused on panic disorders.

Major companies operating in the panic disorders market report are F. Hoffmann-La Roche Ltd, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Baxter Inc, Teva Pharmaceutical Industries Ltd, Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries Ltd, Bausch Health Companies Inc., H. Lundbeck A/S, Shionogi & Co Ltd., Recordati S.p.A, Neurocrine Biosciences Inc, Neuraxpharm, Actavis Plc., Noven Pharmaceuticals Inc., Sumitomo Pharma Co. Ltd, VistaGen Therapeutics, Valeant Pharmaceuticals International Inc., LIFECARE NEURO PRODUCTS LTD.

North America was the largest region in the panic disorders market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the panic disorders market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The panic disorder market consists of revenue earned by entities by providing services such as physical tests, cognitive behavioral therapy (CBT), and psychological evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. The panic disorder market includes sales of tablets and injectables. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Panic Disorders Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on panic disorders market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for panic disorders? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The panic disorders market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Type: Agoraphobia; Social Anxiety Disorder (SAD); Obsessive-Compulsive Disorder (OCD); Bipolar Disorder; Post-Traumatic Stress Disorder (PTSD); Major Depressive Disorder
2) By Treatment: Medication; Beta Blockers; Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs); Benzodiazepines; Anti-Epilepsy; Other Treatments
3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administrations
4) By End Use: Hospital Pharmacies; Retailer Pharmacies; Online Pharmacy Stores
Companies Mentioned: F. Hoffmann-La Roche Ltd; Sanofi S.A; Bristol-Myers Squibb Company; AstraZeneca plc; Abbott Laboratories
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r13404

1. Executive Summary

2. Panic Disorders Market Characteristics

3. Panic Disorders Market Trends And Strategies

4. Panic Disorders Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Panic Disorders Market Size and Growth

5.1. Global Panic Disorders Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Panic Disorders Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Panic Disorders Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Panic Disorders Market Segmentation

6.1. Global Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Agoraphobia
Social Anxiety Disorder (SAD)
Obsessive-Compulsive Disorder (OCD)
Bipolar Disorder
Post-Traumatic Stress Disorder (PTSD)
Specific Phobias
Generalized Anxiety Disorder (GAD)
Major Depressive Disorder
6.2. Global Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Medication
Beta Blockers
Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs)
Benzodiazepines
Anti-Epilepsy
Other Treatments
6.3. Global Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Parenteral
Other Routes Of Administration
6.4. Global Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retailer Pharmacies
Online Pharmacy Stores

7. Panic Disorders Market Regional And Country Analysis

7.1. Global Panic Disorders Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Panic Disorders Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Panic Disorders Market

8.1. Asia-Pacific Panic Disorders Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Panic Disorders Market

9.1. China Panic Disorders Market Overview
9.2. China Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Panic Disorders Market

10.1. India Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Panic Disorders Market

11.1. Japan Panic Disorders Market Overview
11.2. Japan Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Panic Disorders Market

12.1. Australia Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Panic Disorders Market

13.1. Indonesia Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Panic Disorders Market

14.1. South Korea Panic Disorders Market Overview
14.2. South Korea Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Panic Disorders Market

15.1. Western Europe Panic Disorders Market Overview
15.2. Western Europe Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Panic Disorders Market

16.1. UK Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Panic Disorders Market

17.1. Germany Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Panic Disorders Market

18.5. France Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Panic Disorders Market

19.9. Italy Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Panic Disorders Market

20.13. Spain Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Panic Disorders Market

21.1. Eastern Europe Panic Disorders Market Overview
21.2. Eastern Europe Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Panic Disorders Market

22.1. Russia Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Panic Disorders Market

23.1. North America Panic Disorders Market Overview
23.2. North America Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Panic Disorders Market

24.1. USA Panic Disorders Market Overview
24.2. USA Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Panic Disorders Market

25.1. Canada Panic Disorders Market Overview
25.2. Canada Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Panic Disorders Market

26.1. South America Panic Disorders Market Overview
26.2. South America Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Panic Disorders Market

27.1. Brazil Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Panic Disorders Market

28.1. Middle East Panic Disorders Market Overview
28.2. Middle East Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Panic Disorders Market

29.1. Africa Panic Disorders Market Overview
29.2. Africa Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Panic Disorders Market Competitive Landscape And Company Profiles

30.1. Panic Disorders Market Competitive Landscape
30.2. Panic Disorders Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Sanofi S.A
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Bristol-Myers Squibb Company
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. AstraZeneca plc
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Abbott Laboratories
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Panic Disorders Market Other Major And Innovative Companies

31.1. GlaxoSmithKline plc
31.2. Eli Lilly and Company
31.3. Boehringer Ingelheim International GmbH.
31.4. Baxter Inc
31.5. Teva Pharmaceutical Industries Ltd
31.6. Mylan N.V.
31.7. Pfizer Inc.
31.8. Sun Pharmaceutical Industries Ltd
31.9. Bausch Health Companies Inc.
31.10. H. Lundbeck A/S
31.11. Shionogi & Co Ltd.
31.12. Recordati S.p.A
31.13. Neurocrine Biosciences Inc
31.14. Neuraxpharm
31.15. Actavis Plc.

32. Global Panic Disorders Market Competitive Benchmarking

33. Global Panic Disorders Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Panic Disorders Market

35. Panic Disorders Market Future Outlook and Potential Analysis

35.1 Panic Disorders Market In 2028 - Countries Offering Most New Opportunities
35.2 Panic Disorders Market In 2028 - Segments Offering Most New Opportunities
35.3 Panic Disorders Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer